首页|失巢凋亡抵抗通过介导肿瘤免疫逃逸促进前列腺癌进展

失巢凋亡抵抗通过介导肿瘤免疫逃逸促进前列腺癌进展

扫码查看
目的 探讨前列腺癌中失巢凋亡抵抗与免疫微环境互作对肿瘤进展的影响及机制。方法 依据失巢凋亡评分,对公共数据GSE141445中13例前列腺癌患者的单细胞转录组数据鉴定失巢凋亡激活(Anoikis-Epi)和抵抗(Resistance-Epi)肿瘤细胞亚群。对比两个肿瘤亚群和T细胞的细胞间通讯差异,鉴定关键配体-受体互作关系,并在失巢凋亡抵抗细胞系进行验证。通过TIMER和ESTIMATE工具评估样本中的免疫浸润程度,并计算与失巢凋亡抵抗得分的相关性,表征Resist-ance-Epi对T细胞的重塑作用。基于Anoikis-Epi和Resistance-Epi的差异分析筛选出失巢凋亡抵抗相关基因,鉴定相关生物标志物,通过K-M生存分析验证其临床价值。结果 依据失巢凋亡评分,将管腔Ⅰ型和基底-管腔中间型肿瘤细胞分别定义为Anoikis-Epi和Resistance-Epi。临床相关性分析发现,失巢凋亡抵抗与肿瘤进展(Gleason评分,P<0。01;T分期,P<0。01;M分期,P<0。05)和生存变差(P<0。05)相关。细胞间通讯分析发现,Resistance-Epi中Ⅰ型人类白细胞抗原缺失。Bulk数据分析显示失巢凋亡得分与免疫浸润程度显著正相关(R=0。34,P<0。01)。最后,通过联合单细胞以及bulk数据筛选出失巢凋亡抵抗标志物OGN,其表达在失巢凋亡抵抗的细胞系中显著降低(t=3。47,P<0。05),且与免疫浸润程度正相关(R=0。38,P<0。01)。TCGA数据的生存分析结果显示OGN低表达患者无进展生存期显著差于高表达患者(x2=13。2,P<0。01)。结论 失巢凋亡抵抗介导了人类白细胞抗原缺失,减弱了 T细胞免疫,并通过诱导免疫逃逸促进前列腺癌进展。
Anoikis resistance promotes prostate cancer progression via conferring immune evasion
Objective To investigate the impact and mechanisms of anoikis resistance and immune microenvironment interactions on tumor progression in prostate cancer.Methods Single-cell transcriptom-ic data from 13 prostate cancer patients,downloaded from GSE141445,were analyzed to identify two tumor cell subgroups,Anoikis-Epi and Resistance-Epi,based on anoikis activity scores.Differences in intercel-lular communication between the subgroups and T cells were compared to explore how Resistance-Epi af-fects T cells.Validation was conducted using prostate cancer anoikis-resistant cell lines.Immune infiltra-tion was evaluated using TIMER and ESTIMATE tools,and its correlation with anoikis resistance scores was analyzed.Finally,genes associated with anoikis resistance were identified through differential analysis and examined for clinical relevance via survival analysis.Results Based on Anoikis scoring,tumor cells of the luminal subtype and Intermediate subtype were defined as Anoikis-Epi and Resistance-Epi,respec-tively.Clinical correlation analysis revealed that anoikis resistance was associated with tumor progression(Gleason score,P<0.01;T stage,P<0.01;M stage,P<0.05)and poorer survival outcomes(P<0.05).Resistance-Epi exhibited a loss of human leukocyte antigen(HLA)class Ⅰ expression,a finding validated in prostate cancer anoikis-resistant cell lines.Bulk data analysis revealed a significant positive correlation between anoikis scores and immune infiltration levels(R=0.34,P<0.01).Lastly,combined single-cell and bulk data analyses identified OGN as a potential marker of anoikis resistance.OGN expres-sion was significantly reduced in anoikis-resistant cell lines(t=3.47,P<0.05)and positively correlated with immune infiltration(R=0.38,P<0.01).Survival analysis of TCGA dataset showed that patients with low OGN expression had worse progression-free survival compared to those with high expression(x2=13.2,P<0.01).Conclusion Resistance to anoikis mediates the loss of human leukocyte antigens(HLA),weakens T cell immunity,and promotes prostate cancer progression by inducing immune evasion.

Prostate cancerAnoikisImmune infiltrationHuman leukocyte antigen

李璐、王子宇、承逸飞

展开 >

南京大学医学院附属鼓楼医院病理科,南京 210008

东南大学附属中大医院泌尿外科,南京 210009

前列腺癌 失巢凋亡 免疫浸润 人类白细胞抗原

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(12)